Cite
HARVARD Citation
Shaw, L. et al. (n.d.). FV 3 Analysis of cerebrospinal fluid (CSF) biomarkers to predict risk of clinical decline and progression to dementia in patients with mild cognitive impairment and mild cognitive symptoms. Clinical neurophysiology. 130 (8), pp. e121-e122. [Online].